Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:1009-1016

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulz, R.
Right arrow Articles by Heusch, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulz, R.
Right arrow Articles by Heusch, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ASPARTIC ACID
*GLUTAMIC ACID HYDROCHLORIDE

(Circulation. 1998;97:1009-1016.)
© 1998 American Heart Association, Inc.


Basic Science Reports

Positron Emission Tomography Analysis of [1-11C]Acetate Kinetics in Short-term Hibernating Myocardium

Rainer Schulz, MD; Christian Kappeler, PhD; Heinz Coenen, PhD; Andreas Bockisch, MD, PhD; ; Gerd Heusch, MD

From the Department of Pathophysiology, Center of Internal Medicine (R.S., G.H.) and the Department of Nuclear Medicine, Center of Radiology (C.K., H.C., A.B.), University Essen, School of Medicine, FRG.

Correspondence to Gerd Heusch, MD, FESC, FACC, Department of Pathophysiology, Center of Internal Medicine, University Essen, School of Medicine, Hufelandstraße 55, 45122 Essen, FRG.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Modeling of the time-[1-11C]acetate activity curve assumes a constant concentration of labeled tricarboxylic acid cycle intermediates and associated metabolites, such as glutamate and aspartate, which may, however, decrease in short-term hibernating myocardium.

Methods and Results—In 12 anesthetized pigs, [1-11C]acetate was injected as a bolus into the cannulated left anterior descending coronary artery during normoperfusion, inotropic stimulation, and early (5 to 45 minutes) and prolonged ischemia (60 to 90 minutes). Regional myocardial oxygen consumption (MO2, microliters per minute per gram) was measured, and the absence of necrosis was verified by triphenyl tetrazolium chloride staining. Inotropic stimulation increased MO2 from 52.5±7.4 to 195.4±36.2 (mean±SD) and the rate constant (kmono, minutes-1) of [1-11C]acetate clearance from 0.094±0.018 to 0.322±0.076. During early ischemia, MO2 and kmono were decreased to 24.3±8.5 and 0.061±0.011, respectively. Kmono closely correlated to MO2 during normoperfusion, inotropic stimulation, and early ischemia. In short-term hibernating myocardium, however, at an unchanged MO2, kmono increased toward control values (0.080±0.014). Myocardial glutamate and aspartate concentrations (biopsies) decreased to 47±26% and 77±18%; the peak count rate decreased to 66±22% of its respective control value. After correction for the decreases in glutamate and aspartate or in peak count rate, kmono was again decreased (0.050±0.016 or 0.052±0.014, respectively), and a close relationship to MO2 was restored.

Conclusions—Kmono correlates to MO2 in short-term hibernating myocardium when the decreases in aspartate and glutamate or in peak count rate are considered.


Key Words: tomography • ischemia, myocardial • hibernation, myocardial • metabolism


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The clearance of [1-11C]acetate from the myocardium has been used to assess myocardial oxidative metabolism by PET in both animals1 2 3 4 5 6 7 8 and humans.7 9 10 11 12 13 14 15 16 17 18 At increased cardiac workload and myocardial oxygen consumption, the rate constant of the monoexponential fit of the time [1-11C]acetate curve is increased,3 7 and it is decreased during early acute ischemia, when myocardial oxygen consumption is reduced.1 4 8 [1-11C]acetate is activated within the cell and translocated into the mitochondria; more specifically, it is incorporated into different TCA cycle intermediates and equilibrates very rapidly with aspartate and glutamate.19 In isolated rat hearts, the sum of the myocardial aspartate and glutamate concentrations is 8 to 10 times higher than the sum of the TCA cycle metabolites,8 19 20 and the exchange rate between {alpha}-ketoglutarate and glutamate is equal to21 or higher than8 19 22 23 the TCA cycle rate itself. Also in the anesthetized dog, the sum of the myocardial aspartate and glutamate concentrations is 20 times higher than the concentration of succinate,24 the predominant TCA cycle intermediate.8 20 Two minutes after [1-14C]acetate injection in isolated rat hearts, >60% of the total activity injected is found in labeled glutamate,8 whereas labeled TCA cycle metabolites contribute only 8% to total tissue activity.8 With continuous [1-13C]acetate infusion in conscious rabbits, 95% of total [11C] activity within the myocardium is related to labeled glutamate.25

Modeling of myocardial [1-11C]acetate clearance assumes constant sizes of all labeled pools. However, during prolonged hypoxia or ischemia, the myocardial aspartate and glutamate concentrations decrease substantially,8 24 26 thereby potentially affecting the calculation of the rate constant of the monoexponential fit of the time–[1-11C]acetate curve. Particularly during prolonged myocardial ischemia, such as in hibernating myocardium, the determination of myocardial oxidative metabolism may be important.27 28 Therefore, in the present study, the relationship between myocardial [1-11C]acetate clearance and oxygen consumption was assessed during normoperfusion, inotropic stimulation, and early and more prolonged myocardial ischemia by injection of [1-11C]acetate into the LAD of anesthetized swine using an established model of short-term myocardial hibernation29 30 and taking changes in aspartate and glutamate concentrations during prolonged ischemia into consideration.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The experimental protocols used in this study were approved by the bioethical committee of the district of Düsseldorf, and they adhere to the guiding principles of the American Physiological Society.

Experimental Model
The experimental model has been described extensively elsewhere29 30 ; in brief, in 12 enflurane-anesthetized Göttinger miniswine (20 to 40 kg) of either sex, both common carotid arteries were cannulated for measurement of arterial pressure and to supply blood to an extracorporeal circuit. A left lateral thoracotomy was performed, and a micromanometer was placed in the left ventricle through the apex. Ultrasonic dimension gauges were implanted in the LV myocardium to measure the thickness of the anterior and posterior (control) walls. The proximal LAD was cannulated and perfused from an extracorporeal circuit. Before coronary cannulation, the pigs were anticoagulated with sodium heparin. The system included a roller pump, windkessel, and side ports—distal from the windkessel—for the injection of radiolabeled microspheres and [1-11C]acetate and for the measurement of coronary arterial pressure. The large epicardial vein that paralleled the LAD was cannulated at the same site as the coronary artery. Rectal temperature was monitored, and body temperature was kept between 37°C and 38°C with heating pads. Heart rate was controlled by left atrial pacing.

Regional Myocardial Dimensions
End diastole was defined as the point when the first derivative of LV pressure (LV dP/dt) started its rapid upstroke after crossing the zero line. Global LV end systole was defined as the time point of peak negative LV dP/dt and regional end systole as the point of maximal wall thickness within 20 ms before peak negative LV dP/dt.31 Anterior systolic wall thickening and regional myocardial work index are reported.30

Regional Myocardial Blood Flow
Radiolabeled microspheres were injected into the coronary perfusion circuit to determine regional myocardial blood flow. Blood flow to the tissue at the site of the ultrasonic crystals is reported, and this piece of tissue was divided into transmural thirds of approximately equal thickness. Transmural blood flows in different pieces (average weight, 1.08±0.51 g) within and along different heart slices revealed a coefficient of variation of 2.6±1.7%.

Regional Myocardial Oxygen and Lactate Consumption
Oxygen content was measured with anaerobically sampled blood drawn simultaneously from the coronary vein and an artery (Cavitron/LexO2-Con-k, Dr B.G. Schlag, Bergisch Gladbach). Lactate was measured in simultaneously drawn coronary venous and arterial blood samples by use of enzymatic dehydrogenation and subsequent photometry of NADH. Myocardial oxygen (MO2) and lactate consumption were calculated by multiplying the arterial-coronary venous difference by the transmural blood flow at the crystal site.

Myocardial Aspartate and Glutamate Concentrations
Transmural myocardial biopsies ({approx}10 mg each) were taken in six swine of group 1 under control conditions and at the end of the 90-minute ischemic period (see below) with a modified dental drill. Samples requiring more than 1 to 2 seconds for acquisition were not used for this analysis. Samples were homogenized in 0.33 mol/L perchloric acid (Mikro-Dismembrator, B. Braun Melsungen), and the pH of the supernatant was adjusted to 7.2 with 1.1 mol/L K3PO4. Aspartate was determined by transamination with {alpha}-ketoglutarate and glutamic-oxalacetic transaminase, followed by hydrogenation of the formed oxalacetate with NADH and malic dehydrogenase. The decrease in NADH extinction was measured photometrically at 340 nm (model 8452, Hewlett-Packard Co).32 Glutamate was determined by the glutamic dehydrogenase reaction. In this reaction, NADH is formed stoichiometrically when the equilibrium is shifted by the addition of hydrazine sulfate at pH 9.33 The NADH formation was measured at 340 nm.

Radiochemistry
[1-11C]acetate was prepared via carboxylation of methylmagnesium bromide.34 The radiochemical yield, defined as the ratio of 11C activity determined in [1-11C]acetate to the 11C activity at the beginning of the acetate synthesis, averaged 68±7%. The specific activity was in the range of 10 to 20 GBq · µmol-1. Radiochemical purity was determined by high-performance liquid chromatography to be >97.5% by use of a LiChrospher 100 RP-18 column (250x4 mm, 10 µm; Merck) with 0.0003N H2SO4 as eluent (1.0 mL · min-1). For each intracoronary injection, activities of about 1 to 3 mCi 1-[11C]acetate were administered within 1 minute.

Coronary Venous 11CO2
The vein that paralleled the LAD was cannulated and drained into an unpressurized reservoir to avoid recirculation of labeled substance. If [1-11C]acetate is completely metabolized to 11CO2 within the TCA cycle, its clearance from the myocardium reflects myocardial oxygen consumption. The coronary venous blood was sampled during and at 2, 3, 5, 7, 10, 15, 20, 25, 30, 35, and 40 minutes after the injection of [1-11C]acetate. The total activity of the coronary venous blood was counted, and thereafter 11CO2 was eliminated from the coronary venous blood by acidification (pH 1.0) and bubbling with N2 for 5 minutes. The remaining activity within the coronary venous blood was once again assessed, corrected for the activity decay over time, and related to total activity.

Morphology
At the end of each study, the heart was removed and sectioned from base to apex into five transverse slices in a plane parallel to the AV groove. The tissue slices were immersed in a 0.09 mol/L sodium phosphate buffer, pH 7.4, containing 1.0% triphenyl tetrazolium chloride and 8% dextran to verify the absence of infarcted tissue.

Experimental Protocol
Two groups of swine were studied. Under control conditions, the perfusion pump was adjusted so that the minimum coronary arterial pressure was not <70 mm Hg to avoid any initial hypoperfusion. Therefore, mean coronary arterial pressure exceeded peak LV pressure. In both groups of swine, each observation period began with the simultaneous withdrawal of a pair of arterial and coronary venous blood samples. During the blood sampling, microspheres and [1-11C]acetate were injected into the LAD perfusion system. Systemic hemodynamic and regional myocardial dimension data were recorded throughout the microspheres injection.

Group 1 (n=6)
After control measurements, epinephrine was infused intravenously (0.5 to 1.0 µg · kg-1 · min-1) to increase heart rate by {approx}30 bpm. During inotropic stimulation, the perfusion pump was set to maintain mean coronary arterial pressure equal to LV peak pressure to avoid any hypoperfusion. The dose of epinephrine was then maintained, and regional myocardial blood flow, function, and metabolism were measured while [1-11C]acetate was once again injected intracoronarily. Thereafter, heart rate was further increased by {approx}30 bpm with a further increased dose of intravenous epinephrine (1.0 to 4.0 µg · kg-1 · min-1) and additional left atrial pacing, and measurements were once again repeated. Thereafter, the infusion of epinephrine and left atrial pacing were stopped, and restoration of systemic hemodynamics and regional myocardial function was ensured. The perfusion pump was then adjusted to reduce coronary inflow by {approx}50%, a level previously shown to be compatible with the development of short-term hibernating myocardium over 90 minutes.29 30 Flow, function, and myocardial oxygen consumption were measured at 5 minutes of hypoperfusion, whereas the PET data for early ischemia were acquired between 5 and 45 minutes of hypoperfusion. Flow, function, and myocardial oxygen consumption were once more measured at 90 minutes of hypoperfusion, and biopsies for the determination of glutamate and aspartate concentration were taken, whereas the PET data for prolonged ischemia were acquired between 60 and 90 minutes of hypoperfusion.

Group 2 (n=6)
To ensure that prior inotropic stimulation had no impact on the results obtained during ischemia, in a second group of swine, blood flow to the LAD was reduced to 50% immediately after control measurements. Measurements were taken during early and prolonged ischemia, as in group 1. After 90 minutes of ischemia, the myocardium was reperfused for 2 hours.

Data Acquisition
PETs were acquired with an ECAT 953/15 scanner (Siemens/CTI) with an axial field of view of 54 mm. Plane separation was 3.4 mm. The data were reconstructed with a Hanning filter and a frequency cutoff of 0.5 to a 128 matrix. The emission data were corrected for radioactive decay and for attenuation with a transmission scan. A dynamic acquisition protocol with 30 frames of 1 second, 10 frames of 10 seconds, 8 frames of 60 seconds, and 6 frames of 300 seconds was used. The emission data were evaluated with a monoexponential model. Transaxial scans were analyzed. The axial and in-plane spatial resolution of the images was about 9 mm. Because labeled acetate was injected into the cannulated LAD, the perfusion territory was clearly delineated from the left circumflex and right coronary artery perfusion territory. Within the LAD perfusion territory, to avoid influences of mixed perfusion territory (border zone), only the central area with a distance of 2 to 3 mm from the left and right borders was used for analysis. Therefore, the size of the region of interest ranged from 17 to 28 mm in diameter, depending on heart size (different swine) and the intervention used (control versus inotropic stimulation versus ischemia). During ischemia, however, the size of the region of interest remained unchanged within a given animal. Because recirculation of labeled substance was avoided and acetate taken up by the myocardium was metabolized to CO2, the peak-to-noise ratio exceeded 50:1 during normoperfusion and 30:1 during ischemia. The parameters a and kmono of the monoexponential model y(t) =a · e(-kmono · t) were determined pixelwise by linear least-squares fitting. The linear fit was performed over the time interval when the washout of tracer was dominated by 11CO2 (>95% of baseline) and the logarithmic plot of the data was obviously linear. The kmono values for a given region of interest were averaged. Values for kmono thus are mean values of six to eight heart slices, depending on the size of the perfusion territory. The coefficient of variation of measured activity within the region of interest throughout the slices averaged 11±3%, 10±4%, 12±4%, 20±10%, and 24±11% during control conditions, the two degrees of inotropic stimulation, and early and late ischemia, respectively. Within the same region of interest, the peak count rate was determined during control conditions, inotropic stimulation, and early and prolonged ischemia. To account for the different amounts of injected activity, the true count rates are expressed per millicurie of injected activity.

Data Analysis
Hemodynamic data were recorded on an eight-channel recorder and stored directly to the hard disk of an AT-type computer. Hemodynamic and dimension parameters were digitized and recorded over the time period of microspheres injection with CORDAT II software.35 The calculation of all hemodynamic parameters was done on a beat-to-beat basis, and data were then averaged over at least 33 cardiac cycles. kmono was corrected for the observed decreases in the amino acid pool sizes with the following assumptions: If acetate is metabolized completely to CO2, the flux rate through the TCA cycle closely correlates to myocardial oxygen consumption.6 The flux rate through the TCA cycle is given by the product of the TCA cycle intermediates and metabolites in equilibrium with the TCA cycle times kmono. Therefore, as assumed in most instances, at constant pool sizes of TCA cycle intermediates and metabolites such as aspartate and glutamate, kmono indeed correlates to myocardial oxygen consumption. The total concentration of aspartate and glutamate is 8 to 10 times higher than the sum of the TCA cycle metabolites in isolated rat hearts8 19 20 and in the myocardium of anesthetized dogs.24 Therefore, the flux rate can be simplified as the sum of the aspartate and glutamate concentrations times kmono. Alterations in the aspartate and glutamate concentrations, at constant regional myocardial oxygen consumption and thus flux rate through the TCA cycle, will then inversely affect kmono. In conclusion, given the observed changes in the glutamate and aspartate concentrations, kmono was corrected by multiplying kmono with the fraction of the glutamate (Glu) and aspartate (Asp) concentration relative to their control values: kmonocorr=kmonox[(Asp)ischemia+(Glu)ischemia]÷[(Asp)control+(Glu)control].

Similarly, kmono was corrected for the decrease in the peak count rate within the region of interest. The peak count rate during early and more prolonged ischemia was expressed as a fraction of the peak count rate under control conditions and then multiplied with kmono: kmonocorr=kmonox(countsROI)ischemia÷(countsROI)control.

Statistics
Statistical analysis was performed by use of SYSTAT software. Because comparison of systemic hemodynamics, regional myocardial blood flow, function, and metabolism during normoperfusion and ischemia revealed no statistical significant differences between groups 1 and 2 by use of a two-way ANOVA, data at these time points were pooled and compared by use of a one-way ANOVA for repeated measures. When significant differences were detected, individual mean values were compared by use of least-significant-difference post hoc tests. All data are reported as mean±SD, and a value of P<.05 was accepted as indicating a significant difference in mean values. Linear regression analyses between regional myocardial oxygen consumption in the LV area at risk and kmono and corrected kmono were performed.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Systemic Hemodynamics and Regional Myocardial Dimensions
With infusion of epinephrine, heart rate (P<.05), LV end-diastolic pressure (P=NS), peak pressure (P<.05), LV dP/dtmax (P<.05), LV dP/dtmin (P<.05), and coronary blood flow (P<.05) increased (Table 1Down). End-diastolic wall thickness of the anterior myocardium (P=NS) increased, whereas systolic wall thickening, in the presence of increased heart rate and LV peak pressure, remained unaltered. The anterior myocardial work index (P<.05) increased. Further increases in the epinephrine dose in combination with left atrial pacing resulted in a further increase in LV peak pressure (P=NS), LV dP/dtmax and LV dP/dtmin (both P<.05) and coronary blood flow (P=NS). The end-diastolic wall thickness of the anterior myocardium tended to increase (P=NS), and systolic wall thickening tended to decrease (P=NS); the anterior myocardial work index remained unchanged. With ischemia, the LV end-diastolic pressure was increased (P=NS), and LV peak pressure (P=NS), LV dP/dtmax (P=NS), and LV dP/dtmin (P<.05) were reduced. In the presence of significantly reduced coronary blood flow and coronary arterial pressure (both P<.05), end-diastolic wall thickness decreased (P=NS), and both systolic wall thickening and the work index of the anterior myocardium were reduced by {approx}70% (both P<.05). Prolongation of ischemia resulted in no further changes compared with early ischemia, except that systolic wall thickening and the work index of the anterior myocardium tended to be further depressed.


View this table:
[in this window]
[in a new window]
 
Table 1. Systemic Hemodynamics and Regional Myocardial Dimensions During Control Conditions, Inotropic Stimulation, and Low-Flow Ischemia

Coronary Venous Blood Activity
During normoperfusion, >95% of total activity was related to 11CO2 at 5 minutes and longer after the [1-11C]acetate injection (Fig 1ADown). During inotropic stimulation, >95% of total activity was related to 11CO2 already at 3 minutes after the [1-11C]acetate injection, whereas it took almost 7 minutes during early and more prolonged myocardial ischemia (Fig 1BDown) until >95% of total activity was related to 11CO2.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Original data from one animal on total and 11CO2-related activity in coronary venous blood. During control conditions, >95% of total activity was related to 11CO2 at 5 minutes and longer after the [1-11C]acetate injection (A). During acute and prolonged myocardial ischemia (B), it took almost 7 minutes until >95% of total activity was related to 11CO2.

Regional Myocardial Blood Flow, Metabolism, and [1-11C]Acetate Kinetics
Infusion of low-dose epinephrine increased transmural myocardial blood flow (P<.05) and oxygen consumption of the anterior myocardium to twofold (P<.05) (Table 2Down). Myocardial lactate consumption increased (P<.05). The rate constant of the monoexponential fit of the time [1-11C]acetate activity curve (kmono) also increased to twofold (P<.05). Further increases in the epinephrine dose in combination with left atrial pacing resulted in an additional increase in transmural myocardial blood flow to about fourfold the baseline level (P<.05 versus preceding value) and a similar increase in regional myocardial oxygen consumption (P<.05 versus preceding value). Myocardial lactate consumption returned toward control values. The time constant kmono increased further, however, only to 3.5-fold the baseline level (P<.05 versus preceding value). With ischemia, transmural myocardial blood flow and regional myocardial oxygen consumption were reduced by {approx}60% (both P<.05), and lactate consumption under control conditions was reversed to net lactate production (P<.05). The time constant kmono was significantly reduced. With prolonged ischemia, transmural myocardial blood flow and regional myocardial oxygen consumption were not changed, whereas lactate production was attenuated. In the absence of changes in regional myocardial oxygen consumption, kmono returned toward baseline values. Myocardial glutamate and aspartate concentrations averaged 2.19±0.54 and 1.35±0.17 µmol · g-1 wet weight under control conditions, respectively, and were reduced to 47±26% and 77±18% of their control levels (both P<.05 versus control conditions) after 90 minutes of ischemia. The true count rates averaged 35 044±6540 cps/mCi under control conditions, 30 329±7658 cps/mCi during inotropic stimulation, 27 077±8335 cps/mCi during early ischemia, and 22 121±6358 cps/mCi during late ischemia. In the six swine in which decreases in both the peak count rate and glutamate and aspartate concentrations were measured, a close correlation between these two variables existed (percent change in peak count rate=0.99 times the percent change in the glutamate and aspartate concentrations-1.76, r=.84). Correction of kmono for the attenuation in peak count rate during early ischemia decreased kmono from 0.061±0.011 to 0.046±0.021 min-1. After correction for the decreases in glutamate and aspartate or in peak count rate during prolonged ischemia, kmono was again decreased from 0.080±0.014 to 0.050±0.016 or 0.052±0.014 minutes-1, respectively.


View this table:
[in this window]
[in a new window]
 
Table 2. Regional Myocardial Blood Flow, Metabolism, and TCA Cycle Kinetics During Control Conditions, Inotropic Stimulation, and Low-Flow Ischemia

Relationships Between kmono and MO2
A close correlation between kmono and MO2 was observed when data obtained during control conditions, inotropic stimulation, and early ischemia were combined (Fig 2Down). With prolonged ischemia, kmono was increased, so that in short-term hibernating myocardium, all data points relating kmono to regional myocardial oxygen consumption were located above the regression line determined during normoperfusion, inotropic stimulation, and early ischemia (Fig 3ADown). Correction for the significant decrease in labeled pool sizes of aspartate and glutamate in group 1 restored a close relationship between kmono and regional myocardial oxygen consumption also in short-term hibernating myocardium (Fig 3BDown).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 2. A close correlation between kmono and regional myocardial oxygen consumption existed during normoperfusion, inotropic stimulation, and early myocardial ischemia.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 3. Values for kmono in short-term hibernating myocardium were located above the regression line obtained during normoperfusion, inotropic stimulation, and early acute myocardial ischemia (A). Correction for the significant decrease in labeled pool sizes of aspartate and glutamate restored a close relationship between kmono and MO2 also in short-term hibernating myocardium (B).

Correction for the decreases in peak count rate based on all data points obtained throughout the experiment (y=1.11x10-3xx+2.96x10-2, r=.91) only slightly increased the y axis intercept of the relationship between myocardial oxygen consumption and kmono compared with the uncorrected relationship (Fig 4ADown). However, correction for the decreases in peak count rate during prolonged ischemia once more restored a close relationship between kmono and regional myocardial oxygen consumption in short-term hibernating myocardium (Fig 4BDown).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 4. Correction for the decrease in peak count rate early during ischemia slightly decreased the slope of the relationship between myocardial oxygen consumption and kmono determined during normoperfusion, inotropic stimulation, and early ischemia (A). Correction for the decrease in peak count rate during late ischemia once more restored a close relationship between kmono and regional myocardial oxygen consumption in short-term hibernating myocardium (B).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
In short-term hibernating myocardium, the monoexponential rate constant per se does not correctly reflect regional myocardial oxygen consumption. The lack of decrease in the rate constant, in the presence of a significantly reduced regional myocardial oxygen consumption, is related to alterations in the amino acid pool sizes; correction for such a decrease in the pool sizes of glutamate and aspartate or in peak count rate within the region of interest restores a close relationship between the rate constant and regional myocardial oxygen consumption.

Critique of Methods
In the present study, an established model of short-term hibernation was used.29 30 36 A limitation of all controlled experimental studies, including the present one, on myocardial hibernation, however, is the limited observation period.

With systemic administration of the tracer, its delivery will be flow dependent, vary between the region of interest and the reference region, and therefore require normalization to myocardial blood flow. In the present study, however, labeled acetate was injected only into the cannulated LAD, and such normalization to myocardial blood flow was not necessary.

The variation in the measured 11C activity within the region of interest could represent the physiological variation of either regional myocardial blood flow or metabolism. With myocardial tissue with an average weight <100 mg, substantial variations in regional blood flow have indeed been demonstrated.37 Thus, the variation of activity from pixel to pixel might reflect the differences in blood flow distribution, because the pixel volume averaged (2.4x3.4x3 mm3), which, when a density of 1 is assumed, results in an average sample weight of only 25 mg.

The time constants k1 and k2 from a two-compartment model, as first introduced by Armbrecht et al,4 were not calculated. Because of the limited acquisition period, especially during ischemia, a reasonable determination of k2 in the two-compartment model was not possible because of the slow kinetics of the second component. It therefore remains unclear whether the limitations outlined for the monoexponential model with respect to altered amino acid pool sizes are also valid for other compartment models. Because the exchange rate between the TCA cycle and the glutamate pool is known to be rapid,8 19 22 23 it is unlikely that the second, slow component adequately reflects such rapid exchange. The second, slow component of the two-compartment model might, however, reflect the slow conversion of labeled glutamate to glutamine or the further metabolism of glutamine that has already been formed.4 In the present study, lactate consumption increased during the first degree of inotropic stimulation but once again decreased toward control values when inotropic stimulation was further increased. Using 14C-labeled glucose, Massie et al38 demonstrated an increased lactate uptake but also lactate production during dobutamine stimulation in the anesthetized pig in situ, resulting in an almost unchanged net lactate uptake. Similar findings were also obtained in anesthetized dogs.39 The increased lactate production during inotropic stimulation indicates some myocardium with an oxygen supply-demand imbalance.40 Thus, during inotropic stimulation, areas with increased oxygen demand and increased oxygen supply coexist with areas with increased oxygen demand but insufficient oxygen supply.

Myocardial alanine, which can be produced from either aspartate or glutamate during ischemia,24 26 was not measured in the present study. The increase in the alanine concentration by transamination of glutamate would not trap activity within the myocardium because only NH2 is transferred to pyruvate. The myocardial aspartate concentration decreased by 23%. Under the assumptions that aspartate declined continuously during ischemia and that aspartate was completely converted into alanine, a maximal error of (30 minutes/90 minutesx23% total decline in aspartate)= 8% could have occurred during the 30-minute measuring interval. Therefore, by use of the decrease in the glutamate and aspartate concentrations for correction, kmono could be overcorrected by a maximum of 8%.

Amino Acid Metabolism and kmono
Under aerobic conditions, the oxidative metabolism of fatty acids, lactate, and glucose provides most of the cardiac energy requirements. Glutamate participates in the transport of electrons from the cytosol into the mitochondria during oxidation of glucose or lactate (malate-aspartate shuttle).41 This process is strictly dependent on a high concentration of glutamate because of the low affinity of the mitochondrial carrier.42 High rates of ß-oxidation delay and, vice versa, predominant use of glucose accelerate the incorporation of the 13C label into glutamate in isolated rabbit hearts.43 The somewhat smaller increase in kmono than in regional myocardial oxygen consumption during maximal inotropic stimulation (3.5-fold versus 4-fold) observed in the present study could relate to such altered substrate use.

During ischemia, anaerobic glycolysis is the major energy source, and lactate accumulates. In the presence of high concentrations of tissue lactate, the conversion of pyruvate to lactate is retarded owing to the mass action effect of lactate accumulation with subsequent augmentation of glutamate-pyruvate transamination.44 This might result in a net reduction in lactate because alanine is produced from pyruvate; the predominant amino acid for transamination of pyruvate is glutamate.45 Indeed, also in the present study, lactate production was attenuated during prolonged ischemia, and the glutamate concentration significantly decreased. Glutamate is further involved in the clearance of ammonia from the heart. During anoxia and ischemia, ammonia is produced within the myocardium by breakdown of adenosine to inosine.26 46 Alanine, which is formed through transamination of pyruvate (thereby accepting ammonia), acts as a nontoxic carrier of ammonia.47 Therefore, despite an increased glutamate uptake,44 48 the myocardial glutamate concentration is significantly decreased during ischemia.24 26

The decrease in amino acid concentrations during prolonged ischemia—at an equivalent reduction of regional myocardial oxygen consumption during early and late ischemia—was associated with a relative increase in kmono back toward control values. Correction of kmono was performed under the assumption that at an unchanged regional myocardial oxygen consumption, the flux rate through the TCA cycle also remained unchanged. Understandably, then, correction for the decrease in the aspartate and glutamate concentrations restored the close correlation between regional myocardial oxygen consumption and kmono observed during normoperfusion, inotropic stimulation, and early ischemia (Fig 3BUp). Similarly, correction of kmono for the decrease in the peak count rate within the region of interest also restored the close correlation between regional myocardial oxygen consumption and kmono (Fig 4BUp). These findings indicate that the peak count rate and the decay of activity from the myocardium after [1-11C]acetate injection are closely related to the myocardial glutamate and aspartate concentrations.

Clinical Implications
In patients with coronary artery disease, dynamic PET imaging with [1-11C]acetate facilitates the accurate identification of dysfunctional but still viable myocardium, which is capable of recovering systolic function after coronary revascularization.11 13 14 49 [1-11C]acetate even exhibits positive and negative predictive values superior to fluorine-18-gluorodeoxyglucose.49

While in clinical practice the correction of kmono might be less important for the assessment of myocardial viability, such correction offers the potential to better identify the underlying mechanism of contractile dysfunction. It is currently unclear whether hibernation as observed in the clinical setting is a manifestation of and adaptation to a persistent reduction in blood flow50 or the result of repetitive stunning.51 The correct measurement of myocardial oxygen consumption is a prerequisite to quantitatively correlate the observed reduction in function and oxygen demand to that in oxygen supply, and the matching between demand and supply is a hallmark of the classic concept of hibernation.52 53 Whether or not in a clinical setting with a single-spot PET measurement, comparing the region of interest to a reference region, the correction proposed by the present study using serial PET measurements in the region of interest will be useful remains to be determined.


*    Selected Abbreviations and Acronyms
 
LAD = left anterior descending coronary artery
LV = left ventricular/left ventricle
PET = positron emission tomography
TCA = tricarboxylic acid


*    Acknowledgments
 
This work was supported by grants from the German Research Foundation (He 1320/8–1 and Schu 843/3–1). We are grateful to Prof Dr M. Schwaiger for his helpful suggestions.

Received August 27, 1997; revision received October 8, 1997; accepted October 21, 1997.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Brown M, Marshall DR, Sobel BE, Bergmann SR. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation. 1987;76:687–696.[Abstract/Free Full Text]
  2. Brown MA, Myears DW, Bergmann SR. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. J Am Coll Cardiol. 1988;12:1054–1063.[Abstract]
  3. Buxton DB, Nienaber CA, Luxen A, Ratib O, Hansen H, Phelps ME, Schelbert HR. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1–11C] acetate and dynamic positron emission tomography. Circulation. 1989;79:134–142.[Abstract/Free Full Text]
  4. Armbrecht JJ, Buxton DB, Schelbert HR. Validation of [1–11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation. 1990;81:1594–1605.[Abstract/Free Full Text]
  5. Buck A, Wolpers G, Hutchins G, Savas V, Mangner T, Nguyen N, Schwaiger M. Effect of carbon-11 acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med. 1991;32:1950–1957.[Abstract/Free Full Text]
  6. Buxton DB, Schwaiger M, Nguyen A, Phelps ME, Schelbert HR. Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux. Circ Res. 1988;63:628–634.[Abstract/Free Full Text]
  7. Armbrecht JJ, Buxton DB, Brunken RC, Phelps ME, Schelbert HR. Regional myocardial oxygen consumption determined noninvasively in humans with [1–11C] acetate and dynamic positron tomography. Circulation. 1989;80:863–872.[Abstract/Free Full Text]
  8. Ng CK, Huang S-C, Schelbert HR, Buxton DB. Validation of a model for [1–11C]acetate as a tracer of cardiac oxidative metabolism. Am J Physiol. 1994;266:H1304–H1315.[Abstract/Free Full Text]
  9. Henes CG, Bergmann SR, Walsh MN, Sobel BE, Geltman EM. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J Nucl Med. 1989;30:1489–1499.[Abstract/Free Full Text]
  10. Walsh MN, Geltman EM, Brown MA, Henes CG, Weinheimer CJ, Sobel BE, Bergmann SR. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med. 1989;30:1798–1808.[Abstract/Free Full Text]
  11. Gropler RJ, Siegel BA, Sampathkumaran K, Pérez JE, Sobel BE, Bergmann SR, Geltman EM. Dependence of recovery of contractile function of maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol. 1992;19:989–997.[Abstract]
  12. Krivokapich J, Huang S-C, Schelbert HR. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol. 1993;71:1351–1356.[Medline] [Order article via Infotrieve]
  13. Kalff V, Hicks RJ, Hutchins G, Topol E, Schwaiger M. Use of carbon-11 acetate and dynamics positron emission tomography to assess regional myocardial oxygen consumption in patients with acute myocardial infarction receiving thrombolysis or coronary angioplasty. Am J Cardiol. 1993;71:529–535.[Medline] [Order article via Infotrieve]
  14. Czernin J, Porenta G, Brunken R, Krivokapich J, Chen K, Bennett R, Hage A, Fung C, Tillisch J, Phelps ME, Schelbert HR. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation. 1993;88:884–895.[Abstract/Free Full Text]
  15. Vanoverschelde J-J, Wijns W, Depré C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87:1513–1523.[Abstract/Free Full Text]
  16. vom Dahl J, Herman WH, Hicks RJ, Ortiz-Alonso FJ, Lee KS, Allman KC, Wolfe ER Jr, Kalff V, Schwaiger M. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation. 1993;88:395–404.[Abstract/Free Full Text]
  17. Janier MF, Adré-Fouet X, Landais P, Grégoire MC, Lavenne F, Amaya J, Mercier C, Machecourt J, Cinotti L. Perfusion-MVO2 mismatch during inotropic stress in CAD patients with normal contractile function. Am J Physiol. 1996;271:H59–H67.[Abstract/Free Full Text]
  18. Wolpers HG, Burchert W, van den Hoff J, Weinhardt R, Meyer G-J, Lichtlen PR. Assessment of myocardial viability by use of 11C-acetate and positron emission tomography: threshold criteria of reversible dysfunction. Circulation. 1997;95:1417–1424.[Abstract/Free Full Text]
  19. Randle PJ, England PJ, Denton RM. Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in rat heart. Biochem J. 1970;117:677–695.[Medline] [Order article via Infotrieve]
  20. Russell RR, Taegtmeyer H. Changes in citric acid cycle flux and anaplerosis antedate in functional decline in isolated rat hearts utilizing acetoacetate. J Clin Invest. 1991;87:384–390.
  21. Nuutinen EM, Peuhkurinen KJ, Pietiläinen EP, Hiltunen JK, Hassinen IE. Elimination and replenishment of tricarboxylic acid-cycle intermediates in myocardium. Biochem J. 1981;194:867–875.[Medline] [Order article via Infotrieve]
  22. Robitaille PL, Rath DP, Skiner TE, Abduljalil AM, Hamlin RL. Transaminase reaction rates, transport activities and TCA cycle analysis by post-steady state 13C NMR. Magn Reson Med. 1993;30:262–266.[Medline] [Order article via Infotrieve]
  23. Chance EM, Seeholzer SH, Kobayashi K, Williamson JR. Mathematical analysis of isotope labeling in the citric acid cycle with applications to 13C NMR studies in perfused rat hearts. J Biol Chem. 1983;258:13785–13794.[Abstract/Free Full Text]
  24. Wiesner RJ, Deussen A, Borst M, Schrader J, Grieshaber MK. Glutamate degradation in the ischemic dog heart: contribution to anaerobic energy production. J Mol Cell Cardiol. 1989;21:49–59.[Medline] [Order article via Infotrieve]
  25. Lewandowski ED. Nuclear magnetic resonance evaluation of metabolic and respiratory support of work load in intact rabbit hearts. Circ Res. 1992;70:576–583.[Abstract/Free Full Text]
  26. Peuhkurinen KJ, Takala TES, Nuutinen EM, Hassinen LE. Tricarboxylic acid cycle metabolites during ischemia in isolated perfused rat heart. Am J Physiol. 1983;244:H281–H288.[Abstract/Free Full Text]
  27. Schelbert HR. Positron emission tomography for the assessment of myocardial viability. Circulation. 1991;84(suppl I):I-122-I-131.
  28. Bonow RO. The hibernating myocardium: implications for management of congestive heart failure. Am J Cardiol. 1995;19:17A–25A.
  29. Schulz R, Rose J, Martin C, Brodde OE, Heusch G. Development of short-term myocardial hibernation: its limitation by the severity of ischemia and inotropic stimulation. Circulation. 1993;88:684–695.[Abstract/Free Full Text]
  30. Heusch G, Rose J, Skyschally A, Post H, Schulz R. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart: inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation. 1996;93:1556–1566.[Abstract/Free Full Text]
  31. Theroux P, Ross Jr. J, Franklin D, Kemper WS, Sasayama S. Regional myocardial function in the conscious dog during acute coronary occlusion and responses to morphine, propranolol, nitroglycerin, and lidocaine. Circulation. 1976;53:302–314.[Abstract/Free Full Text]
  32. Bergmeyer HU, Bernt E, Möllering H, Pfleiderer G. L-Aspartat und L-Asparagin. In: Bergmeyer HU, ed. Methoden der enzymatischen Analyse. Weinheim, Germany: Verlag Chemie; 1970:1651–1655.
  33. Bernt E, Bergmeyer HU. L-Glutamat: Bestimmung mit Glutamat-Dehydrogenase und NAD. In: Bergmeyer HU, ed. Methoden der enzymatischen Analyse. Weinheim, Germany: Verlag Chemie; 1970:1659–1663.
  34. Pike VW, Eakins MN, Allan RM, Selwyn AP. Preparation of [1–11C] acetate: an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot. 1982;33:505–512.[Medline] [Order article via Infotrieve]
  35. Skyschally A, Schulz R, Heusch G. Cordat II: A new program for data acquisition and on-line calculation of hemodynamic and regional myocardial dimension parameters. Comput Biol Med. 1993;23:359–367.[Medline] [Order article via Infotrieve]
  36. Horvath KA, Smith WJ, Laurence RG, Schoen FJ, Appleyard RF, Cohn LH. Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol. 1995;25:258–263.[Abstract]
  37. Austin RE, Aldea GS, Coggins DL, Flynn AE, Hoffman JIE. Profound spatial heterogeneity of coronary reserve: discordance between patterns of resting and maximal myocardial blood flow. Circ Res. 1990;67:319–331.[Abstract/Free Full Text]
  38. Massie BM, Schwartz GG, Garcia J, Wisneski JA, Weiner MW, Owens T. Myocardial metabolism during increased work states in the porcine left ventricle in vivo. Circ Res. 1994;74:64–73.[Abstract/Free Full Text]
  39. Zhang J, Duncker DJ, Xu Y, Zhang Y, Path G, Merkle H, Hendrich K, From AHL, Bache RJ, Ugurbil K. Transmural bioenergetic response of normal myocardium to high workstates. Am J Physiol. 1995;268:H1891–H1905.[Abstract/Free Full Text]
  40. Guth BD, Wisneski JA, Neese RA, White FC, Heusch G, Mazer D, Gertz EW. Myocardial lactate release during ischemia in swine: relation to regional blood flow. Circulation. 1990;81:1948–1958.[Abstract/Free Full Text]
  41. Safer B. The metabolic significance of the malate-aspartate cycle in heart. Circ Res. 1975;37:527–533.[Free Full Text]
  42. LaNoue KF, Schoolwerth AC. Metabolite transport in mitochondria. Annu Rev Biochem. 1979;48:871–922.[Medline] [Order article via Infotrieve]
  43. Yu X, White LT, Doumen C, Damico LA, LaNoue KF, Alpert NM, Lewandowski ED. Kinetic analysis of dynamic 13C NMR spectra: metabolic flux, regulation, and compartmentation in hearts. Biophys J. 1995;69:2090–2102.[Abstract/Free Full Text]
  44. Mudge GH Jr, Mills RM Jr, Taegtmeyer H, Gorlin R, Lesch M. Alterations of myocardial amino acid metabolism in chronic ischemic heart disease. J Clin Invest. 1976;58:1185–1192.
  45. Felig P, Pozefsky T, Cahill ME. Alanine: key role in gluconeogenesis. Science. 1970;167:1003–1004.[Abstract/Free Full Text]
  46. Krivokapich J, Keen RE, Phelps ME, Shine KI, Barrio JR. Effects of anoxia on kinetics of [13N] glutamate and 13NH3 metabolism in rabbit myocardium. Cardiovasc Res. 1987;60:505–515.
  47. Taegtmeyer H, Peterson MB, Ragavan VV, Ferguson AG, Lesch M. De novo alanine synthesis in isolated oxygen-deprived rabbit myocardium. J Biol Chem. 1977;252:5010–5018.[Free Full Text]
  48. Knapp WH, Helus F, Ostertag H, Tillmanns H, Kübler W. Uptake and turnover of L-(13N)-glutamate in the normal human heart and in patients with coronary artery disease. Eur J Nucl Med. 1982;7:211–215.[Medline] [Order article via Infotrieve]
  49. Gropler RJ, Geltman EM, Sampathkumaran K, Perez JE, Schechtman KB, Conversano A, Sobel BE, Bergmann SR, Siegel BA. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol. 1993;22:1587–1597.[Abstract]
  50. Rahimtoola SH. Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation. 1996;94:3055–3061.[Free Full Text]
  51. Vanoverschelde J-LJ, Wijns W, Borgers M, Heyndrickx GR, Depre C, Flameng W, Melin JA. Chronic myocardial hibernation in humans: from bedside to bench. Circulation. 1997;95:1961–1971.[Free Full Text]
  52. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985;72(suppl V):V-123-V-135.
  53. Ross J Jr. Myocardial perfusion-contraction matching: implications for coronary heart disease and hibernation. Circulation. 1991;83:1076–1083.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
P. Knaapen, T. Germans, J. Knuuti, W. J. Paulus, P. A. Dijkmans, C. P. Allaart, A. A. Lammertsma, and F. C. Visser
Myocardial Energetics and Efficiency: Current Status of the Noninvasive Approach
Circulation, February 20, 2007; 115(7): 918 - 927.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Heusch, R. Schulz, and S. H. Rahimtoola
Myocardial hibernation: a delicate balance
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H984 - H999.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J., May 2, 2004; 25(10): 815 - 836.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. G. Camici and D. P. Dutka
Repetitive stunning, hibernation, and heart failure: contribution of PET to establishing a link
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H929 - H936.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Wiggers, M. Noreng, P. K. Paulsen, M. Bottcher, H. Egeblad, T. T. Nielsen, and H. E. Botker
Energy stores and metabolites in chronic reversibly and irreversibly dysfunctional myocardium in humans
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 100 - 108.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Schulz and G Heusch
Hibernating myocardium
Heart, December 1, 2000; 84(6): 587 - 594.
[Full Text]


Home page
CirculationHome page
E. D. Lewandowski, N. M. Alpert, G. Heusch, R. Schulz, C. Kappeler, H. H. Coenen, and A. Bockisch
Factors Influencing Isotope Equilibrium Rates Affect 11C PET Analysis • Response
Circulation, February 23, 1999; 99 (7): 975 - 978.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. HEUSCH
Hibernating Myocardium
Physiol Rev, October 1, 1998; 78(4): 1055 - 1085.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted